These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 6772663
1. Graves' disease associated with elevated serum thyroxine-binding globulin concentrations. Yabu Y, Amino N, Nakatani K, Ichihara K, Azukizawa M, Miyai K. J Clin Endocrinol Metab; 1980 Aug; 51(2):325-9. PubMed ID: 6772663 [No Abstract] [Full Text] [Related]
2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis. Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y. J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274 [Abstract] [Full Text] [Related]
3. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. Clifton-Bligh P, Burke G. J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532 [Abstract] [Full Text] [Related]
4. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. Tamai H, Hayaki I, Kawai K, Komaki G, Matsubayashi S, Kuma K, Kumagai LF, Nagataki S. J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989 [Abstract] [Full Text] [Related]
5. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K. J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731 [Abstract] [Full Text] [Related]
6. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs]. Takamatsu J. Nihon Naibunpi Gakkai Zasshi; 1983 Mar 20; 59(3):295-303. PubMed ID: 6190686 [No Abstract] [Full Text] [Related]
7. Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease. Földes J, Gyertyánfy G, Tako J, Bános C, Gesztesi E. Endokrinologie; 1973 Jan 20; 61(1):52-64. PubMed ID: 4739850 [No Abstract] [Full Text] [Related]
8. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis. Yoshida K, Sakurada T, Kaise N, Kaise K, Kitaoka H, Fukazawa H, Yamamoto M, Saito S, Yoshinaga K. J Clin Endocrinol Metab; 1982 Jul 20; 55(1):185-8. PubMed ID: 6176591 [Abstract] [Full Text] [Related]
9. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease. Clifton-Bligh P, Silverstein GE, Burke G. J Clin Endocrinol Metab; 1974 Apr 20; 38(4):531-8. PubMed ID: 4206830 [No Abstract] [Full Text] [Related]
12. Neonatal Graves' Eye Disease. Segal KL, Nelson CC. Ophthalmology; 2017 May 20; 124(5):673. PubMed ID: 28433126 [No Abstract] [Full Text] [Related]
13. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T. N Engl J Med; 1991 Apr 04; 324(14):947-53. PubMed ID: 1900575 [Abstract] [Full Text] [Related]
14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE. J Clin Endocrinol Metab; 1996 Sep 04; 81(9):3283-8. PubMed ID: 8784084 [Abstract] [Full Text] [Related]
15. Serum ferritin, iron and transferrin in women with thyrotoxic Graves' disease before and after methimazole treatment. Zwirska-Korczala K, Buntner B, Sobieraj H, Ostrowska Z, Kniazewski B, Swietochowska E. Acta Physiol Pol; 1990 Sep 04; 41(7):163-8. PubMed ID: 2136311 [Abstract] [Full Text] [Related]
16. [Behavior of the levels of free triiodothyronine, triiodothyronine, free thyroxine, thyroxine, thyrotropin and thyroxine-binding globulin in the serum of children with nephrotic syndrome]. Liappis N, Rao GS. Klin Padiatr; 1985 Sep 04; 197(5):423-6. PubMed ID: 3934459 [Abstract] [Full Text] [Related]
17. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW. Clin Endocrinol (Oxf); 2004 Jun 04; 60(6):676-81. PubMed ID: 15163329 [Abstract] [Full Text] [Related]
18. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities. Kuzuya N, Chiu SC, Ikeda H, Uchimura H, Ito K, Nagataki S. J Clin Endocrinol Metab; 1979 Apr 04; 48(4):706-11. PubMed ID: 581876 [No Abstract] [Full Text] [Related]
19. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. Yamada T, Sato A, Komiya I, Nishimori T, Ito Y, Terao A, Eto S, Tanaka Y. J Clin Endocrinol Metab; 2000 Aug 04; 85(8):2775-8. PubMed ID: 10946880 [Abstract] [Full Text] [Related]
20. Decreased secretion of gonadotropins in a patient with Graves' disease. Hakamata M, Itoh M, Sudo Y, Katada E, Miyata N. Exp Clin Endocrinol Diabetes; 1996 Aug 04; 104(1):85-8. PubMed ID: 8750576 [Abstract] [Full Text] [Related] Page: [Next] [New Search]